Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, is celebrating a significant milestone.
MS patients with history of neuro-ophthalmic syndromes perform poorly on visual neuropsychological testing
Scientists found that individuals with multiple sclerosis (MS) who had a history of neuro-ophthalmic syndromes performed poorly on visual neuropsychological tasks. The article, “Neuro-ophthalmic syndromes and processing speed in multiple sclerosis,” wa…
Cegedim Announces the Signature of an Agreement to Acquire Nightingale’s US Business
BOULOGNE-BILLANCOURT, France–(BUSINESS WIRE)–Regulatory News: Cegedim, an innovative technology and services company, today announced the signature of an agreement for the acquisition of the US based Practice Management business of Nightingale Informatix Corporation by its US subsidiary Pulse System, Inc. The acquisition includes the assets of Nightingale’s Medrium, Ridgemark, Secure Connect and Northern Health Products. Jeff Burton, the Pulse Systems President and CEO stated that “We are exc
Uncategorized
Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment
‘Failure to Communicate’ Drives Misdiagnosis
(MedPage Today) — Electronic medical records also need to be improved, says Mark Graber, MD
Uncategorized
Nobel Prize recognizes advancements in parasitic disease treatment
The 2015 Nobel Assembly at Karolinska Institutet has awarded this year’s prize for physiology or medicine to three researchers for their contributions in developing novel therapies against malaria and roundworm parasite infection, according to a press release.Youyou Tu, from the China Academy of Traditional Chinese Medicine, was awarded one half of the prize for the discovery of artemisinin, while the other was jointly awarded to William C. Campbell, PhD, emeritus research fellow at Drew University, New Jersey, and Satoshi Ōmura, PhD, emeritus professor at Kitasato University, Japan, for the discovery of avermectin.